CLINICA CAYANGA


Clinical Updates
 

Clinical Daily Updates
Rodolfo T. Rafael, M.D. 
 

 

 

Alzheimer's Disease
Arthritis
Asthma
Benign Prostatic Hypertrophy
Chronic Lymphocytic Leukemia
Coronary Artery Disease
Depression
Diabetes Mellitus
Dyspepsia
Erectile Dysfunction
Fatty Liver
Gallstone
Hepatitis
Hypertension
Lung Cancer
Mesothelioma
Metabolic Syndrome
Obesity
Pneumonia
Pregnancy
Prostate Cancer
Sinusitis
Stroke
Tinnitus

 Falls prevented by calcium/vitamin D

Clinical Question:
Does calcium plus vitamin D therapy decrease falls in older women?

Bottom Line:
Long-term dietary cholecalciferol-calcium supplementation reduces the odds of falling in ambulatory older women by 46%, and especially in less active women by 65%. Supplementation had a neutral effect in men independent of their physical activity level.

Reference:
Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women. Arch Intern Med 2006;155:424-30.

Study Design:
Randomized controlled trial (double-blinded)

Synopsis:
A recent meta-analysis found that cholecalciferol (vitamin D) should reduce falls by more than 20%. However, little is known about whether supplemental cholecalciferol plus calcium citrate malate will lower the long-term risk of falling in men, active older individuals, and older individuals with higher 25-hydroxyvitamin D levels. The author studied the effect of 3-year supplementation with cholecalciferol-calcium on the risk of falling at least once in 199 men and 246 women 65 years or older and living at home. Individuals received 700 IU of cholecalciferol plus 500 mg of calcium citrate malate per day or placebo in a randomized double-blind manner. Subjects were classified as less physically active if physical activity was below the median level. Low 25-hydroxyvitamin D levels were classified as those below 32 ng/mL (<80 nmol/L). In 3 years, 55% of women and 45% of men reported at least 1 fall. Mean +/- SD baseline 25-hydroxyvitamin D levels were 26.6 +/- 12.7 ng/mL (66.4 +/- 31.7 nmol/L) in women and 33.2 +/- 14.2 ng/mL (82.9 +/- 34.9) in men. Cholecalciferol-calcium significantly reduced the odds of falling in women (odds ratio [OR], 0.54; 95% confidence interval [CI], 0.30-0.97), but not in men (OR, 0.93; 95% CI, 0.50-1.72). Fall reduction was most pronounced in less active women (OR, 0.35; 95% CI, 0.15-0.81). Baseline 25-hydroxyvitamin D level did not modulate the treatment effect.

Patient Information

Health For Life

Medical Library

Breaking Medical News
Clinical Tools
Coronary Risk Profile
Dermatology
Diabetes Corner
Evidence-Based Medicine
Free Medical Books
Free Medical Journal
History Taking and Physical Examination
Hows on Making Diagnostic Examination
Medical Journal (popular)
Medical Organizations
Medical Professional News
Neurological and Psychiatric Problems in Clinical Practice
Palm Tools
Medical Notes
Medical Physiology (Lecture)
Medical Resources
Medical Search
Online Clinical Calculator
Scientific Meeting
Online Sari- Sari Store
Please support Clinica Cayanga Medical Resources by purchasing gift items at

Home | Introduction | Scheduling a Visit| Laboratory Work Reaching Us | Map to our Office | About the Doctors

 

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.

 ©2005-2006 Clinica Cayanga. All rights reserved.
clinica.cayanga@gmail.com